WATSON 796 (Sulfasalazine 500 mg)

Pill imprint WATSON 796 has been identified as Sulfasalazine 500 mg.

Sulfasalazine is used in the treatment of rheumatoid arthritis; ulcerative colitis, maintenance; psoriatic arthritis; crohn's disease; ulcerative colitis, active (and more), and belongs to the drug classes 5-aminosalicylates, sulfonamides. There is no proven risk in humans during pregnancy. Sulfasalazine 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 796

Sulfasalazine 500 mg WATSON 796
Sulfasalazine 500 mg WATSON 796  Front
Sulfasalazine 500 mg WATSON 796  Back
Sulfasalazine 500 mg WATSON 796
Sulfasalazine
Imprint:
WATSON 796
Strength:
500 mg
Color:
Yellow
Size:
13.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
5-aminosalicylates
Sulfonamides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0796
Inactive Ingredients:
magnesium stearate
corn starch
stearic acid
sodium starch glycolate type A potato

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)